Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12746793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the first case of Miller Fisher syndrome (opthalmoplegia, ataxia, and areflexia) associated with lactic acidosis as an adverse effect of receipt of an antiretroviral regimen containing stavudine. We review this syndrome in the context of recent descriptions of neuromuscular toxicities attributed to nucleoside analogue reverse-transcriptase inhibitor-induced mitochondrial toxicity.
Medical subject headings
- Acidosis, Lactic
- Miller Fisher Syndrome
- Reverse Transcriptase Inhibitors
- Stavudine